Bradley Foster & Sargent Inc. CT Purchases 351 Shares of Xylem Inc. (NYSE:XYL)

Bradley Foster & Sargent Inc. CT lifted its position in Xylem Inc. (NYSE:XYLFree Report) by 0.7% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 47,883 shares of the industrial products company’s stock after purchasing an additional 351 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in Xylem were worth $6,494,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. EverSource Wealth Advisors LLC increased its stake in Xylem by 68.8% in the first quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock valued at $25,000 after acquiring an additional 77 shares during the last quarter. Whittier Trust Co. of Nevada Inc. increased its stake in Xylem by 3.5% in the first quarter. Whittier Trust Co. of Nevada Inc. now owns 2,317 shares of the industrial products company’s stock valued at $299,000 after acquiring an additional 79 shares during the last quarter. Addison Advisors LLC increased its stake in Xylem by 5.8% in the second quarter. Addison Advisors LLC now owns 1,486 shares of the industrial products company’s stock valued at $202,000 after acquiring an additional 82 shares during the last quarter. Waycross Investment Management Co increased its stake in Xylem by 1.8% in the second quarter. Waycross Investment Management Co now owns 4,895 shares of the industrial products company’s stock valued at $664,000 after acquiring an additional 87 shares during the last quarter. Finally, Bleakley Financial Group LLC increased its stake in Xylem by 2.3% in the first quarter. Bleakley Financial Group LLC now owns 4,042 shares of the industrial products company’s stock valued at $522,000 after acquiring an additional 90 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.

Xylem Stock Performance

Xylem stock opened at $132.86 on Thursday. The company has a current ratio of 1.85, a quick ratio of 1.33 and a debt-to-equity ratio of 0.19. The firm has a 50-day moving average of $133.85 and a 200-day moving average of $134.08. The firm has a market cap of $32.27 billion, a P/E ratio of 47.28, a P/E/G ratio of 2.34 and a beta of 1.04. Xylem Inc. has a 1-year low of $87.59 and a 1-year high of $146.08.

Xylem (NYSE:XYLGet Free Report) last posted its earnings results on Tuesday, July 30th. The industrial products company reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. Xylem had a net margin of 9.11% and a return on equity of 9.48%. The company had revenue of $2.17 billion during the quarter, compared to analyst estimates of $2.14 billion. During the same period in the prior year, the business posted $0.98 earnings per share. Xylem’s revenue for the quarter was up 26.0% on a year-over-year basis. Sell-side analysts expect that Xylem Inc. will post 4.26 EPS for the current year.

Xylem Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 26th. Shareholders of record on Thursday, August 29th will be issued a $0.36 dividend. The ex-dividend date of this dividend is Thursday, August 29th. This represents a $1.44 annualized dividend and a yield of 1.08%. Xylem’s dividend payout ratio (DPR) is presently 51.25%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. TD Cowen reissued a “hold” rating and issued a $138.00 target price on shares of Xylem in a research note on Tuesday, September 3rd. Royal Bank of Canada raised their price objective on Xylem from $160.00 to $163.00 and gave the company an “outperform” rating in a research note on Wednesday, July 31st. Argus raised their price objective on Xylem from $146.00 to $165.00 and gave the company a “buy” rating in a research note on Wednesday, May 29th. Stifel Nicolaus raised their price objective on Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a research note on Wednesday, July 31st. Finally, Robert W. Baird raised their price objective on Xylem from $155.00 to $170.00 and gave the company an “outperform” rating in a research note on Wednesday, July 31st. Five research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, Xylem has a consensus rating of “Moderate Buy” and an average target price of $147.54.

Read Our Latest Stock Report on XYL

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.